Targacept, Inc. · Winston-Salem, NC United States ·(NASDAQ (GM): TRGT)
Company Description
Phone: 336-480-2100
Fax: 336-480-2107
View Targacept, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Depressed because you can't smoke anymore? Targacept might be able to help as it researches how to put the nervous system's nicotinic receptors to good use. The biotechnology company is the result of nicotine research conducted by R.J. Reynolds Tobacco , which spun off the firm in 2000. Targacept's drug candidates address conditions related to cognitive impairment, depression, and pain by targeting neuronal nicotinic receptors (NNRs) in the nervous system using non-nicotine compounds. The firm hopes its drug candidates will reproduce the therapeutic effects of NNR interaction without the side effects of nicotine. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Targacept, Inc. Financials
| Company Type | Public - NASDAQ (GM): TRGT Single Location |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $20.1 |
| 2008 Employees | 113 |
Targacept, Inc. Executives
19 executives listed for Targacept, Inc.'s Winston-Salem, NC location.
| Title | Name & Bio | Contact |
| Chairman | Mark Skaletsky | Network |
| President, CEO, and Director | J. Donald deBethizy | Network |
| VP, CFO, Treasurer, and Assistant Secretary | Alan Musso | Network |
Competition
Top Targacept, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!